Anti-Inflammatory Action Research suggests GHK-Cu may reduce inflammatory markers (IL-6, TNF-), with potential applications in damaged tissue and oxidative stress models
Skip your next scheduled dose if advised
History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
Unknown long-term safety of self-injection: The safety data belong to the controlled 16 mg implant, not to repeated grey-market self-injection at uncontrolled doses and purity
If the COA isnt available, ask CorePeptidesOfficial.com directly
Testing costs remain modest and provide valuable guidance for adjusting supplementation